Acadia Healthcare down 7% after hours on Q3 miss, guidance cut

Acadia Healthcare (NASDAQ:ACHC) Q3 results:

Revenue: $777.3M (+2.2%).

Net income: $42.6M (-7.8%); non-GAAP net income: $46.0M (-4.6%); EPS: $0.48 (-9.4%); non-GAAP EPS: $0.52 (-5.5%); non-GAAP EBITDA: $146.6M (-1.5%).

2019 guidance: Revenue: $3.100B – 3.125B from $3.150B – 3.175B; non-GAAP EBITDA: $584M – 589M from $610M – 620M; non-GAAP EPS: $2.00 – 2.05 from $2.15 – 2.23.

Shares down 7% after hours.

Previously: Acadia Healthcare EPS misses by $0.03, misses on revenue (Nov. 5)

https://seekingalpha.com/news/3514955-acadia-healthcare-7-percent-hours-q3-miss-guidance-cut

Supernus Pharmaceuticals EPS misses by $0.08, misses on revenue

Supernus Pharmaceuticals (NASDAQ:SUPN): Q3 GAAP EPS of $0.54 misses by $0.08.

Revenue of $102.14M (-0.8% Y/Y) misses by $6.56M.

Press Release

https://seekingalpha.com/news/3514948-supernus-pharmaceuticals-eps-misses-0_08-misses-revenue

Arcus Biosciences EPS misses by $0.06, beats on revenue

Arcus Biosciences (NYSE:RCUS): Q3 GAAP EPS of -$0.51 misses by $0.06.

Revenue of $1.75M (-59.2% Y/Y) beats by $0.21M.

Press Release

https://seekingalpha.com/news/3514951-arcus-biosciences-eps-misses-0_06-beats-revenue

Akcea Therapeutics EPS beats by $0.19, misses on revenue

Akcea Therapeutics (NASDAQ:AKCA): Q3 GAAP EPS of -$0.34 beats by $0.19.

Revenue of $20.62M (+7.2% Y/Y) misses by $1.92M.

Press Release

https://seekingalpha.com/news/3514920-akcea-therapeutics-eps-beats-0_19-misses-revenue

Inogen Q3 sales down 4%; earnings down 58%

Inogen (NASDAQ:INGN) Q3 results:

Revenue: $91.8M (-3.7%); sales: $86.4M (-3.7%); direct-to-consumer sales: $37.8M (-1.7%).

Net income: $6.9M (-57.9%); EPS: $0.31 (-57.5%), non-GAAP EBITDA: $12.8M (-21.5%).

2019 guidance: Revenue: $370M – 375M (unch); net income: $23M – 25M (unch); non-GAAP EBITDA: $49M – 51M (unch).

2020 guidance: Revenue: $410M – 415M; net income: $25M – 27M; non-GAAP EBITDA: $56M – 58M, net positive cash flow.

Previously: Inogen EPS beats by $0.08, beats on revenue (Nov. 5)

https://seekingalpha.com/news/3514862-inogen-q3-sales-4-percent-earnings-58-percent

American Renal EPS beats by $0.30, misses on revenue

American Renal (NYSE:ARA): Q3 Non-GAAP EPS of $0.33 beats by $0.30; GAAP EPS of $0.11 beats by $0.15.

Revenue of $211.43M (+2.8% Y/Y) misses by $4.09M.

Press Release

https://seekingalpha.com/news/3514887-american-renal-eps-beats-0_30-misses-revenue

Evolent Health EPS beats by $0.03, beats on revenue

Evolent Health (NYSE:EVH): Q3 Non-GAAP EPS of -$0.09 beats by $0.03; GAAP EPS of -$0.30 misses by $0.04.

Revenue of $220.14M (+46.8% Y/Y) beats by $2.24M.

Press Release

https://seekingalpha.com/news/3514901-evolent-health-eps-beats-0_03-beats-revenue